公开(公告)号：US12274775B2

公开(公告)日：2025-04-15

申请号：US17428309

申请日：2019-02-04

Applicant: SYMRISE AG

Inventor： Peter Mayser ,  Manuel Pesaro ,  Gerhard Schmaus ,  Jessica Grieger ,  Nikolas Bugdahn

IPC: A61K8/37 ,  A61K8/34 ,  A61Q5/00 ,  A61Q17/00 ,  A61Q19/00

Abstract: The present invention primarily relates to a fatty acid ester or mixture of two or more fatty acid esters or mixture comprising one or more fatty acid esters, wherein the fatty acid ester or one, two, three or more, preferably all, of the fatty acid ester(s) is/are selected from the group consisting of 3-hydroxypropyl caprylate, glyceryl monocaprylate, 3-hydroxypropyl undecylenate and glyceryl monoundecylenate, for use in the treatment of an excess of Malassezia on the skin surface of mammals, preferably of humans. The present invention further relates to particular mixtures or products, and to the cosmetic, non-therapeutic use of fatty acid esters or of mixtures or products comprising fatty acid esters as defined herein to reduce the amount of Malassezia on the skin surface of mammals, preferably of humans.

公开(公告)号：US20160100574A1

公开(公告)日：2016-04-14

申请号：US14893720

申请日：2014-05-20

Applicant: SYMRISE AG

Inventor： Manuel Pesaro ,  Oskar Koch ,  Gerhard Schmaus ,  Antje Köhler ,  Jessica Grieger

IPC: A01N31/04 ,  A61Q5/00 ,  A61K8/34 ,  A61Q5/12 ,  A61Q19/00 ,  A61Q19/08 ,  A61Q17/04 ,  A61Q5/06 ,  A61Q11/00 ,  C11D3/48 ,  C11B9/00 ,  A61Q13/00 ,  C11D3/20 ,  A23L3/3463 ,  A61Q15/00

CPC classification number: A01N31/04 ,  A01N31/02 ,  A23L3/34635 ,  A23V2002/00 ,  A61K8/34 ,  A61K8/345 ,  A61K2800/524 ,  A61Q5/006 ,  A61Q5/02 ,  A61Q5/06 ,  A61Q5/12 ,  A61Q9/02 ,  A61Q9/04 ,  A61Q11/00 ,  A61Q13/00 ,  A61Q15/00 ,  A61Q17/005 ,  A61Q17/04 ,  A61Q19/002 ,  A61Q19/004 ,  A61Q19/005 ,  A61Q19/007 ,  A61Q19/08 ,  A61Q19/10 ,  C11B9/00 ,  C11D3/2068 ,  C11D3/48

Abstract: Suggested is an antimicrobial agent comprising at least one glycerylether of formula (I) in which R1 represents a benzyl, methylbenzyl, phenlethyl, or phenylpropyl radical, or a glycerylether of formula (II) in which R2 stands for a linear or branched alkyl radical having 2 to 12 carbon atoms, on condition that in case of glycerylethers of formula (II) two or three of said species are present.

Abstract translation: 建议包含至少一种式（I）的糖精醚的抗微生物剂，其中R 1表示苄基，甲基苄基，苯乙基或苯基丙基，或式（II）的糖基醚，其中R 2表示直链或支链烷基， 2至12个碳原子，条件是在式（II）的糖衣醚的情况下，存在所述物质的两个或三个。